Michael Michelson - HCA Holdings Independent Director
| HCA Etf | USD 310.31 5.20 1.70% |
Mr. Michael W. Michelson is Independent Director of HCA Holdings Inc. He was appointed Senior Advisory Partner of KKR Co. L.P. in January 2018. From 2009 to 2018, he was a member of KKR Management LLC, a private equity investment manager and the general partner of KKR Co. L.P. Before that, Mr. Michelson was a member of the limited liability company which served as the general partner of KKR Co. L.P. from 1996 to 2009. Prior to that, he was a general partner of KKR Co. L.P. Mr. Michelson previously served as a director of the Company from 2006 to 2016. He was a director of Zimmer Biomet Holdings, Inc., a medical device company, since June 2015 and was previously a director of Biomet, Inc. from 2007 to 2015. Among other qualifications, Mr. Michelson was selected a director in light of his extensive experience in the oversight of companies with complex operations and capital structures, his focus on health care companies and his proven leadership abilities. This experience will be beneficial in providing financial, investment and health care expertise to the Board.
| Age | 69 |
| Tenure | 6 years |
| Address | One Park Plaza, Nashville, TN, United States, 37203 |
| Phone | 615 344 9551 |
| Web | https://www.hcahealthcare.com |
HCA Holdings Management Efficiency
The company has Return on Asset of 0.1108 % which means that on every $100 spent on assets, it made $0.1108 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1234 %, implying that it generated $0.1234 on every 100 dollars invested. HCA Holdings' management efficiency ratios could be used to measure how well HCA Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
| Showing other executives | One Year Return | ||
| Rick Lund | Veeva Systems Class | N/A | |
| Timothy | Cigna Corp | N/A | |
| George Kurian | Cigna Corp | 54 | |
| Robert Mittelstaedt | Laboratory of | 74 | |
| William Zollars | Cigna Corp | 70 | |
| Martha Marsh | Edwards Lifesciences Corp | 72 | |
| Donna Shalala | Mednax Inc | 75 | |
| Michael Fernandez | Mednax Inc | 66 | |
| Ramona Sequeira | Edwards Lifesciences Corp | 55 | |
| Steven Loranger | Edwards Lifesciences Corp | 69 | |
| Kerrii Anderson | Laboratory of | 63 | |
| JeanLuc Belingard | Laboratory of | 72 | |
| Wesley Schack | Edwards Lifesciences Corp | 74 | |
| Peter Neupert | Laboratory of | 65 | |
| Timothy Barabe | Veeva Systems Class | 67 | |
| Gary Gilliland | Laboratory of | 63 | |
| Garheng Kong | Laboratory of | 45 | |
| Ronald Codd | Veeva Systems Class | 64 | |
| Richelle Parham | Laboratory of | 53 | |
| Stanley Meresman | Guardant Health | 71 | |
| Pascal Goldschmidt | Mednax Inc | 65 | |
Management Performance
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.11 |
HCA Holdings Money Managers
| William Rutherford, Chief Financial Officer, Executive Vice President | ||
| Kathleen JD, Senior Officer | ||
| Andrea Smith, Independent Director | ||
| Christopher Wyatt, Senior Vice President Controller | ||
| Michael Cuffe, Executive Vice President, Chief Clinical Officer | ||
| William Frist, Independent Director | ||
| Jonathan Perlin, President - Clinical and Physician Services Group, Chief Medical Officer | ||
| J Morrow, Senior Vice President - Finance, Treasurer | ||
| Robert Waterman, Senior Vice President General Counsel, Chief Labor Relations Officer | ||
| Terence Arkel, Chief Division | ||
| Geoffrey Meyers, Independent Director | ||
| Joseph Sowell, Senior Vice President Chief Development Officer | ||
| Charles Gressle, President Division | ||
| Jana Davis, Senior Vice President - Corporate Affairs | ||
| Dan Miller, President Division | ||
| Deborah Reiner, Senior Vice President of Marketing and Communications | ||
| Hugh Johnston, Independent Director | ||
| Timothy McManus, President Group | ||
| Donald Stinnett, Senior Vice President Controller | ||
| Arnold Moore, President - Service Line and Operations Integration | ||
| Jeff Cohen, Senior Vice President - Government Relations | ||
| Sammie Mosier, Senior Vice President Chief Nurse Executive | ||
| Juan Vallarino, Senior Vice President - Employer and Payer Engagement | ||
| Paul Paslick, Senior Vice President, Chief Information Officer | ||
| Joseph Steakley, Senior Vice President - Internal Audit Services | ||
| Erol FACHE, President Group | ||
| Thomas Frist, Chairman of the Board | ||
| Michael Marks, Senior Finance | ||
| Charles Holliday, Independent Director | ||
| Tim McManus, President of HCA's Capital Division | ||
| Annie Lamont, Independent Director | ||
| Jon Foster, President of American Group | ||
| Jay Light, Independent Presiding Director | ||
| Charles Hall, President of National Group | ||
| Bruce Moore, President - Service Line and Operations Integration | ||
| Wayne Riley, Independent Director | ||
| Samuel Hazen, Chief Executive Officer, Director | ||
| Greg Lowe, President Division | ||
| Milton Johnson, Chairman and CEO | ||
| David Anderson, Senior Vice President - Finance, Treasurer | ||
| Troy Villarreal, President - HCA's Gulf Coast Division | ||
| Michael Michelson, Independent Director | ||
| Lyn Ketelsen, Chief Patient Experience Officer | ||
| NancyAnn DeParle, Independent Director | ||
| John Rowe, Independent Director | ||
| John Steele, Chief Human Resource Officer, Senior Vice President | ||
| Robert Dennis, Independent Director | ||
| Chad Wasserman, Senior Officer | ||
| Sandra Morgan, Senior Vice President — Provider Relations | ||
| MD Frist, Founder Emeritus | ||
| Jane Englebright, Senior Vice President and Chief Nursing Officer | ||
| Michael McAlevey, Senior Vice President and Chief Legal Officer | ||
| Heather Rohan, President of HCA's TriStar Division | ||
| Martin Paslick, Senior Officer | ||
| Phillip Billington, Senior Vice President - Internal Audit Services | ||
| Kathryn Torres, Senior Vice President - Payer Contracting and Alignment | ||
| Jeffrey Cohen, Senior Relations | ||
| Ann Lamont, Independent Director | ||
| Alan Yuspeh, Senior Vice President Chief Ethics and Compliance Officer | ||
| Kathleen Whalen, Senior Vice President Chief Ethics and Compliance Officer | ||
| MD MBA, Executive Officer | ||
| William Morrow, Senior Vice President - Finance, Treasurer | ||
| Frank CFA, Vice Relations | ||
| Mark Kimbrough, Vice President - Investor Relations | ||
| Joseph III, Senior Officer | ||
| Jim Brown, Chief Center | ||
| Victor Campbell, Senior Vice President | ||
| Brian Cook, President Division | ||
| Meg Crofton, Independent Director | ||
| Ravi Chari, Senior Vice President - Clinical Excellence | ||
| Jennifer Berres, Chief Human Resource Officer, Senior Vice President |
HCA Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is HCA Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 125.75 B | ||||
| Shares Outstanding | 264.48 M | ||||
| Shares Owned By Insiders | 27.22 % | ||||
| Shares Owned By Institutions | 64.95 % | ||||
| Number Of Shares Shorted | 2.6 M | ||||
| Price To Earning | 13.57 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards HCA Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, HCA Holdings' short interest history, or implied volatility extrapolated from HCA Holdings options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HCA Holdings. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade HCA Etf refer to our How to Trade HCA Etf guide.Note that the HCA Holdings information on this page should be used as a complementary analysis to other HCA Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
The market value of HCA Holdings is measured differently than its book value, which is the value of HCA that is recorded on the company's balance sheet. Investors also form their own opinion of HCA Holdings' value that differs from its market value or its book value, called intrinsic value, which is HCA Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HCA Holdings' market value can be influenced by many factors that don't directly affect HCA Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HCA Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if HCA Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HCA Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.